Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Infertility, Female | 3 | 2022 | 763 | 1.470 |
Why?
|
Infertility, Male | 2 | 2024 | 397 | 1.460 |
Why?
|
Receptors, KIR3DS1 | 3 | 2019 | 9 | 1.440 |
Why?
|
Killer Cells, Natural | 11 | 2022 | 2211 | 1.110 |
Why?
|
Histocompatibility Antigens Class I | 4 | 2022 | 1361 | 0.930 |
Why?
|
Self Care | 4 | 2023 | 799 | 0.880 |
Why?
|
Women's Rights | 2 | 2022 | 66 | 0.860 |
Why?
|
Ubiquinone | 1 | 2024 | 181 | 0.810 |
Why?
|
Sophora | 1 | 2022 | 3 | 0.810 |
Why?
|
Carbon Tetrachloride | 1 | 2022 | 72 | 0.790 |
Why?
|
Iran | 10 | 2024 | 763 | 0.730 |
Why?
|
Telephone | 1 | 2024 | 630 | 0.710 |
Why?
|
Zinc Sulfate | 1 | 2020 | 18 | 0.700 |
Why?
|
Glycyrrhiza | 1 | 2020 | 11 | 0.700 |
Why?
|
Hyperbilirubinemia, Neonatal | 1 | 2020 | 30 | 0.690 |
Why?
|
Diphenhydramine | 1 | 2020 | 63 | 0.680 |
Why?
|
Plant Extracts | 2 | 2022 | 497 | 0.680 |
Why?
|
Reproductive Rights | 1 | 2020 | 31 | 0.670 |
Why?
|
Stomatitis, Aphthous | 1 | 2020 | 51 | 0.670 |
Why?
|
Quality of Life | 7 | 2024 | 13490 | 0.590 |
Why?
|
Prediabetic State | 1 | 2023 | 548 | 0.560 |
Why?
|
Triage | 1 | 2024 | 997 | 0.550 |
Why?
|
Infertility | 1 | 2023 | 655 | 0.550 |
Why?
|
Receptors, Natural Killer Cell | 4 | 2022 | 56 | 0.540 |
Why?
|
Women's Health | 2 | 2023 | 2082 | 0.520 |
Why?
|
Antioxidants | 1 | 2024 | 1673 | 0.510 |
Why?
|
Dietary Supplements | 4 | 2024 | 3445 | 0.490 |
Why?
|
Receptors, KIR3DL1 | 3 | 2019 | 27 | 0.450 |
Why?
|
Autistic Disorder | 1 | 2023 | 1240 | 0.420 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2020 | 862 | 0.410 |
Why?
|
Curcumin | 2 | 2024 | 97 | 0.410 |
Why?
|
Anxiety | 2 | 2024 | 4672 | 0.400 |
Why?
|
Digoxin | 1 | 2012 | 246 | 0.380 |
Why?
|
Aptamers, Nucleotide | 1 | 2012 | 163 | 0.370 |
Why?
|
Lymphocyte Activation | 5 | 2019 | 5505 | 0.360 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2019 | 4415 | 0.340 |
Why?
|
HIV-1 | 5 | 2022 | 6961 | 0.340 |
Why?
|
Receptors, KIR2DL1 | 2 | 2019 | 13 | 0.340 |
Why?
|
Receptors, KIR2DL3 | 2 | 2019 | 15 | 0.340 |
Why?
|
Aggressive Periodontitis | 1 | 2009 | 59 | 0.320 |
Why?
|
Insulin Resistance | 1 | 2023 | 3986 | 0.320 |
Why?
|
Chemokine CCL4 | 2 | 2019 | 127 | 0.320 |
Why?
|
Interleukin-1alpha | 1 | 2009 | 88 | 0.320 |
Why?
|
Wound Healing | 1 | 2020 | 2809 | 0.310 |
Why?
|
HIV Infections | 8 | 2022 | 17569 | 0.290 |
Why?
|
Depression | 2 | 2024 | 8230 | 0.280 |
Why?
|
Decision Making | 1 | 2020 | 3953 | 0.260 |
Why?
|
HLA-B Antigens | 2 | 2019 | 330 | 0.260 |
Why?
|
Double-Blind Method | 5 | 2024 | 12465 | 0.250 |
Why?
|
Colic | 1 | 2024 | 43 | 0.240 |
Why?
|
Urinary Incontinence, Urge | 1 | 2024 | 50 | 0.220 |
Why?
|
Interleukin-1beta | 1 | 2009 | 1027 | 0.210 |
Why?
|
Domestic Violence | 1 | 2024 | 180 | 0.210 |
Why?
|
Qualitative Research | 3 | 2024 | 3140 | 0.210 |
Why?
|
Humans | 39 | 2024 | 768166 | 0.200 |
Why?
|
Urinary Incontinence, Stress | 1 | 2024 | 180 | 0.200 |
Why?
|
HLA Antigens | 4 | 2022 | 1334 | 0.200 |
Why?
|
Receptors, KIR | 2 | 2019 | 114 | 0.200 |
Why?
|
Midwifery | 1 | 2023 | 131 | 0.190 |
Why?
|
Multiple Trauma | 1 | 2024 | 369 | 0.190 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily C | 1 | 2021 | 38 | 0.190 |
Why?
|
Poisoning | 1 | 2023 | 252 | 0.190 |
Why?
|
Superoxide Dismutase | 1 | 2024 | 596 | 0.190 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2022 | 2204 | 0.190 |
Why?
|
Albumins | 1 | 2024 | 577 | 0.190 |
Why?
|
HIV Seronegativity | 2 | 2021 | 210 | 0.180 |
Why?
|
Genotype | 5 | 2021 | 13045 | 0.180 |
Why?
|
Aspartate Aminotransferases | 1 | 2022 | 414 | 0.170 |
Why?
|
Receptors, KIR2DL2 | 1 | 2019 | 6 | 0.170 |
Why?
|
Mouthwashes | 1 | 2020 | 57 | 0.170 |
Why?
|
HLA-C Antigens | 1 | 2019 | 146 | 0.160 |
Why?
|
Animals, Genetically Modified | 1 | 2024 | 1563 | 0.160 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12252 | 0.160 |
Why?
|
Oxytocin | 1 | 2023 | 404 | 0.160 |
Why?
|
Lysosomal-Associated Membrane Protein 1 | 1 | 2018 | 25 | 0.160 |
Why?
|
Prevalence | 3 | 2024 | 15869 | 0.150 |
Why?
|
Self Concept | 1 | 2024 | 1043 | 0.150 |
Why?
|
Bilirubin | 1 | 2020 | 438 | 0.150 |
Why?
|
Marriage | 1 | 2020 | 351 | 0.150 |
Why?
|
Rats, Wistar | 1 | 2022 | 1888 | 0.150 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2019 | 306 | 0.140 |
Why?
|
Germany | 1 | 2020 | 883 | 0.140 |
Why?
|
Socioeconomic Factors | 2 | 2022 | 7852 | 0.140 |
Why?
|
Female | 20 | 2024 | 397192 | 0.140 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15662 | 0.140 |
Why?
|
Receptors, CCR5 | 1 | 2019 | 491 | 0.140 |
Why?
|
Phototherapy | 1 | 2020 | 368 | 0.140 |
Why?
|
Breast Feeding | 1 | 2024 | 1363 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 10399 | 0.130 |
Why?
|
Adult | 13 | 2024 | 223646 | 0.120 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 26379 | 0.120 |
Why?
|
Educational Status | 1 | 2022 | 2515 | 0.120 |
Why?
|
Drosophila melanogaster | 1 | 2024 | 1726 | 0.120 |
Why?
|
Psychometrics | 2 | 2022 | 3063 | 0.120 |
Why?
|
Diabetes, Gestational | 1 | 2024 | 1263 | 0.120 |
Why?
|
Bariatric Surgery | 1 | 2024 | 1001 | 0.110 |
Why?
|
HLA-A Antigens | 1 | 2014 | 223 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 18065 | 0.110 |
Why?
|
Postmenopause | 1 | 2023 | 2518 | 0.110 |
Why?
|
SELEX Aptamer Technique | 1 | 2012 | 19 | 0.100 |
Why?
|
Male | 11 | 2024 | 364719 | 0.100 |
Why?
|
Oxidative Stress | 1 | 2024 | 3139 | 0.100 |
Why?
|
Clinical Chemistry Tests | 1 | 2012 | 59 | 0.100 |
Why?
|
Gene Frequency | 3 | 2021 | 3623 | 0.100 |
Why?
|
Biotinylation | 1 | 2012 | 185 | 0.100 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3858 | 0.100 |
Why?
|
Viral Load | 1 | 2021 | 3396 | 0.100 |
Why?
|
Young Adult | 7 | 2024 | 60066 | 0.100 |
Why?
|
Serum Albumin, Bovine | 1 | 2012 | 320 | 0.100 |
Why?
|
Anxiety Disorders | 1 | 2023 | 2748 | 0.090 |
Why?
|
Inpatients | 1 | 2023 | 2566 | 0.090 |
Why?
|
Intensive Care Units | 1 | 2024 | 3800 | 0.090 |
Why?
|
Guinea Pigs | 1 | 2012 | 1310 | 0.090 |
Why?
|
Antibodies | 1 | 2019 | 2421 | 0.090 |
Why?
|
Infant, Premature | 1 | 2020 | 2124 | 0.090 |
Why?
|
Interferon-gamma | 1 | 2018 | 3160 | 0.080 |
Why?
|
Pain Measurement | 1 | 2020 | 3583 | 0.080 |
Why?
|
Linkage Disequilibrium | 2 | 2017 | 1997 | 0.080 |
Why?
|
Cardiotonic Agents | 1 | 2012 | 542 | 0.080 |
Why?
|
HIV Seropositivity | 1 | 2014 | 966 | 0.080 |
Why?
|
Multiple Sclerosis | 1 | 2024 | 3250 | 0.080 |
Why?
|
Blood Glucose | 1 | 2023 | 6430 | 0.080 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2009 | 766 | 0.070 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2022 | 3447 | 0.070 |
Why?
|
Pregnancy | 3 | 2024 | 30256 | 0.070 |
Why?
|
Alleles | 3 | 2021 | 6894 | 0.070 |
Why?
|
Cattle | 1 | 2012 | 3819 | 0.070 |
Why?
|
Oxidation-Reduction | 1 | 2012 | 2227 | 0.070 |
Why?
|
Gene Expression | 1 | 2019 | 7598 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2022 | 20227 | 0.060 |
Why?
|
Rats | 1 | 2022 | 23760 | 0.060 |
Why?
|
Cell Line | 1 | 2018 | 15597 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10873 | 0.060 |
Why?
|
APACHE | 1 | 2024 | 268 | 0.060 |
Why?
|
Infant, Newborn | 2 | 2024 | 26422 | 0.060 |
Why?
|
Sexual Behavior | 2 | 2024 | 2197 | 0.050 |
Why?
|
Ligands | 2 | 2022 | 3284 | 0.050 |
Why?
|
Codes of Ethics | 1 | 2023 | 61 | 0.050 |
Why?
|
Thiadiazoles | 1 | 2003 | 63 | 0.050 |
Why?
|
Middle Aged | 7 | 2024 | 223492 | 0.050 |
Why?
|
Alprazolam | 1 | 2023 | 103 | 0.050 |
Why?
|
Glasgow Coma Scale | 1 | 2024 | 574 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2024 | 8759 | 0.050 |
Why?
|
Models, Molecular | 1 | 2012 | 5403 | 0.050 |
Why?
|
Lactation | 1 | 2024 | 392 | 0.050 |
Why?
|
Obesity | 1 | 2024 | 13090 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8748 | 0.050 |
Why?
|
Quinolones | 1 | 2003 | 389 | 0.040 |
Why?
|
Apolipoprotein E4 | 1 | 2024 | 712 | 0.040 |
Why?
|
Heart | 1 | 2012 | 4446 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2009 | 4249 | 0.040 |
Why?
|
Perforin | 1 | 2019 | 167 | 0.040 |
Why?
|
Animals | 3 | 2024 | 169246 | 0.040 |
Why?
|
Receptors, KIR2DL5 | 1 | 2017 | 1 | 0.040 |
Why?
|
Apolipoproteins E | 1 | 2024 | 1461 | 0.040 |
Why?
|
Genetic Load | 1 | 2017 | 15 | 0.040 |
Why?
|
Granzymes | 1 | 2019 | 277 | 0.040 |
Why?
|
Adaptive Immunity | 1 | 2022 | 733 | 0.030 |
Why?
|
Fluorescence | 1 | 2019 | 756 | 0.030 |
Why?
|
Counseling | 1 | 2023 | 1554 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2024 | 1904 | 0.030 |
Why?
|
Adolescent | 2 | 2023 | 89169 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2003 | 1397 | 0.030 |
Why?
|
Cytomegalovirus Infections | 1 | 2021 | 837 | 0.030 |
Why?
|
Menopause | 1 | 2023 | 1656 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2023 | 1088 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2019 | 1864 | 0.030 |
Why?
|
Mothers | 1 | 2024 | 2209 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2017 | 1340 | 0.030 |
Why?
|
Piperazines | 1 | 2003 | 2554 | 0.030 |
Why?
|
Mycobacterium tuberculosis | 1 | 2003 | 1930 | 0.030 |
Why?
|
Critical Illness | 1 | 2024 | 2756 | 0.020 |
Why?
|
Telomere | 1 | 2017 | 944 | 0.020 |
Why?
|
Haplotypes | 1 | 2017 | 2722 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4568 | 0.020 |
Why?
|
Critical Care | 1 | 2023 | 2715 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2024 | 4530 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2003 | 7477 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14783 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 2 | 2003 | 1967 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22291 | 0.020 |
Why?
|
Aged | 3 | 2024 | 171504 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 21538 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2014 | 2744 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18349 | 0.010 |
Why?
|
Child | 2 | 2023 | 80917 | 0.010 |
Why?
|
Enoxacin | 1 | 2003 | 11 | 0.010 |
Why?
|
Norfloxacin | 1 | 2003 | 24 | 0.010 |
Why?
|
Esters | 1 | 2003 | 212 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 12795 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36535 | 0.010 |
Why?
|
Acetates | 1 | 2003 | 317 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 17140 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 19015 | 0.010 |
Why?
|
Ciprofloxacin | 1 | 2003 | 313 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2023 | 59629 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 81762 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 54926 | 0.010 |
Why?
|
Bacteria | 1 | 2003 | 2216 | 0.010 |
Why?
|
Concepts
(199)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_